Abstract:Background: The insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme (ACE) gene has been implicated in susceptibility to major depressive disorder (MDD) and its treatment response; however, a large number of studies have reported inconsistent results. The aim of this study is to examine the role of I/D polymorphism of ACE gene in MDD risk and its treatment response by a case-control study and meta-analysis.Methods: Three hundred and sixty eight depressed patients who met DSM-IV criteria for major depressive disorder and 371 normal controls were recruited for the study. We searched Pubmed, Embase, CNKI, Wanfang, and Weipu database, covering all papers until March 31, 2011. Statistical analysis was performed using the software STATA 10.0.Results: Genotype and allele distributions of ACE I/D were not significantly different between case and control groups. No significant association with treatment response was discovered. A total of 2479 cases and 7744 controls in 15 case-control studies were included in this meta-analysis. The results indicated that the D/D homozygote carriers had an 18% increased risk of MDD, when compared with the homozygotes I/I and heterozygote I/D [odds ratio (OR) = 1.18, 95% confidence interval (CI):1.04-133]. In the subgroup analysis, significant elevated risks were associated with D/D homozygote carriers in Caucasians (OR= 1.20 and 95% Cl: 1.04-1.38 for D/D vs I/D + I/I) but not in Asians. Moderate trends of an increased risk in the D allele carriers from total sample (OR, 1.15; 95% CI: 1.02-1.30) was also observed. The D/D homozygote carriers were associated with a 28% increased risk of MDD relative to the homozygotes I/I (OR 1.28; 95% CI: 1.11-1.49). In subgroup analysis, Caucasians showed significant association (OR 1.30; 95% CI: 1.09-1.56). No association was found in the Asian groups. No publication bias was observed in this meta-analysis by using the Egger method.Conclusions: The ACE I/D polymorphism is not associated with MDD and its treatment response in a Chinese case control study. Meta-analysis evidence suggests that the I/D polymorphism of ACE gene may be a risk factor of major depressive disorder in Caucasians. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.

Association Of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism With Panic Disorder Risk: A Meta-Analysis

Association of the Genetic Polymorphism of Angiotensin-Converting Enzyme and Idiopathic Dilated Cardiomyopathy

Association Between Angiotensin-Converting Enzyme Gene Insertion/deletion Polymorphism and Pancreatitis Risk: A Meta-Analysis

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis.

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis

Angiotensin-converting Enzyme Insertion/deletion Polymorphism Contributes to Ischemic Stroke Risk: a Meta-Analysis of 50 Case-Control Studies.

The angiotensin converting enzyme insertion/deletion polymorphism and intracranial aneurysm: a meta-analysis of case-control studies.

Meta-analysis of the association between the insertion/deletion polymorphism in ACE gene and coronary heart disease among the Chinese population.

Meta-analysis of the association between angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk.

The I/D Polymorphism of Angiotensin-Converting Enzyme Gene in Major Depressive Disorder and Therapeutic Outcome: A Case-Control Study and Meta-Analysis

Angiotensin-Converting Enzyme I/D Polymorphism is Associated with Copd Risk in Asian Population: Evidence from A Meta-Analysis

The ACE insertion/deletion polymorphism and its association with metabolic syndrome.

Relationship Between Angiotensin-Converting Enzyme Insertion/deletion Gene Polymorphism and Prostate Cancer Susceptibility.

Impact Of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphisms On Dilated Cardiomyopathy And Hypertrophic Cardiomyopathy Risk

Meta-analysis of the association between the insertion/deletion polymorphism in gene and coronary heart disease among the Chinese population

Angiotensin-converting Enzyme Gene Deletion Allele Increases the Risk of Left Ventricular Hypertrophy: Evidence from a Meta-Analysis

Association Between Angiotensin-Converting Enzyme Insertion/deletion Gene Polymorphism and End-Stage Renal Disease Susceptibility.

Association Between the Angiotensin‐converting Enzyme Gene Insertion/deletion Polymorphism and First‐episode Patients with Schizophrenia in a Chinese Han Population

Association Between Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism and Atrial Fibrillation: A Meta-Analysis

Angiotensin-converting Enzyme Insertion/deletion Polymorphism is Not a Major Determining Factor in the Development of Sporadic Alzheimer Disease: Evidence from an Updated Meta-Analysis.

The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis